RNA Polymerase Backtracking Promotes Type III-A CRISPR DNA Targeting
Angel J Hernandez VieraiD, Naomi R Gross, Patricia Q TraniD, Omar Shahin, James C KosmopoulosiD, Karthik AnantharamaniD, Charlie Y MoiD
Abstract
Type III CRISPR-Cas systems provide transcription-dependent immunity against mobile genetic elements, yet the mechanism underlying their DNA targeting remains unclear. Although the type III effector Cas10-Csm functions as a single-stranded DNase in vitro, type III systems eliminate double-stranded DNA targets in vivo, suggesting that transcription generates critical DNA substrates. Here, we show that conserved RNA polymerase anti-backtracking factors, such as GreA, selectively inhibit DNA-targeting of type III immunity. GreA overexpression abolishes protection against both phages and conjugative plasmids, whereas mutations that disrupt GreA anti-backtracking activity eliminate this effect. In contrast, immunity mediated by the type II CRISPR-Cas system or the auxiliary type III RNase Csm6 remain unaffected, demonstrating that GreA specifically suppresses Cas10-dependent DNA interference. These findings identify RNA polymerase backtracking as a key determinant of Cas10-Csm activity and support a model in which arrested transcription complexes generate substrates for DNA degradation, opening up new anti-CRISPR strategies against type III.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Interference Requirements of Type III CRISPR-Cas Systems from Thermus thermophilus
K. Karneyeva, M. Kolesnik, … K. Severinov·bioRxiv·Sep 3, 2023
- Critical roles for 'housekeeping' nucleases in Type III CRISPR-Cas immunity
L. Chou-Zheng, A. Hatoum-Aslan·bioRxiv·Jul 18, 2022
- Structural and functional insights into the type III-E CRISPR-Cas immunity
Xi Liu, Laixing Zhang, … Yue Feng·bioRxiv·Aug 22, 2022
- Characterization of a novel type III CRISPR-Cas effector provides new insights into the allosteric activation and suppression of the Cas10 DNase
Jinzhong Lin, Mingxia Feng, … Qunxin She·Cell DiscoveryPeer-reviewed·May 11, 2020
- Type III CRISPR-Cas systems generate cyclic oligoadenylate second messengers to activate Csm6 RNases
O. Niewoehner, C. Garcia-Doval, … M. Jinek·bioRxiv·Jun 23, 2017
- BaCas12a3 represents a new subtype of type V CRISPR effector with collateral activity toward tRNA
Shiqi Ji, Xin Li, … Qunxin She·bioRxiv·Jan 16, 2026